Is there a molecular analysis that can help us define a subgroup of patients?

Date 29 September 2014
Event ESMO 2014
Session Primary surgery or neoadjuvant chemotherapy for ovarian cancer: How should we select the patients?
Topics Ovarian Cancer
Pathology/Molecular Biology
Translational Research
Presenter Charlie Gourley
Authors C. Gourley
  • Mrc Institute Of Genetics And Molecular Medicine, Edinburgh Cancer Research UK Centre, EH4 2XR - Edinburgh/GB